Details of the Drug | DrugMAP

General Information of Drug (ID: DM6135B)

Drug Name

CLR 131

Indication

Disease Entry	ICD 11	Status	REF
Waldenstrom macroglobulinemia	2A85.4	Phase 2	[1]
Head and neck cancer	2D42	Phase 1	[2]
Multiple myeloma	2A83	Phase 1	[3]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

PubChem CID: 16045365
TTD ID: DNCA54

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT02952508) Study of CLR 131 in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT04105543) CLR 131 Combined With Radiation for Head and Neck Cancer. U.S. National Institutes of Health.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)